Form D · Biotechnology
Oculogica, Inc.
New Richmond, WI · CIK 0001613810
Offering snapshot reported May 13, 2024 · SEC filing
- Reported sold
- $7.57M Offering amount: $18M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 26, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 13, 2024 | Initial | $7,569,130 | No comparison | 24 | SEC filing |
| Jun 23, 2022 | Initial | $4,048,963 | No comparison | 20 | SEC filing |
| Jan 3, 2020 | Initial | $8,071,764 | No comparison | 41 | SEC filing |
| Mar 17, 2016 | Initial | $1,689,998 | No comparison | 8 | SEC filing |
| Jul 16, 2014 | Initial | $599,970 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-513105
Source: Form D, filed May 13, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jill Enos | Director |
| Jim Flannigan | Director |
| Jason Huang | Director |
| Bilal Khan | Director |
| Pratipatti Laxminarain | Director |
| Robert Ritlop | Executive |
| Rosina Samadani | Director, Executive |
| Uzma Samadani | Director |
| Kathryn Swintek | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1477 S. Knowles Ave. #110 F
New Richmond, WI, 54017
New Richmond, WI, 54017